Monthly Archives: May 2014

Coordinated communication optimising patient care

Make sure you ask to have any investigations/results copied in to your treating Doctors

Historically patients saw one general practitioner (GP) for most of their life. Now, patients may see more than one GP. Sometimes it may be convenient for patients to see one GP close to work and another close to home. Some people reside in more than one location during the year and see a different GP in each place. Whatever the reason, it is invaluable for all treating GPs and other relevant doctors to receive copies of any results of investigations that may ensue from each consultation.

This is particularly important for follow up appointments, allowing your Doctor to be informed at the time of your consultation, and avoiding the need to search for results of investigations performed elsewhere. Enabling results to be made available to all treating GPs and other relevant doctors can reduce unnecessary duplication of investigations, and allow recurrent health issues eg urinary tract infections or chronic conditions such as diabetes to be consistently monitored.

Patients can play a vital role in their health management by reminding their doctors to send copies of investigation results and any other relevant correspondence to other doctors involved in their care.

Dr […]

May 19th, 2014|Clinic News|

Shingles vaccine, Zostavax

The risk of shingles in Australia has doubled between 2000 and 2010.Shingles will often cause a painful, debilitating illness with extensive skin lesions, and the possibility of long term nerve damage. About 30% of people with shingles develop Post herpetic neuralgia, defined as significant pain lasting more than 3 months after shingles.

The shingles vaccine has been recommended by Australian Immunisation authorities since 2009, but the vaccine has rarely been available, so we did not promote it until now, when it is readily available.

Zostavax is the adult varicella vaccine, and is 14 times more potent than the childhood varicella or chickenpox vaccine.

It is recommended for adults over the age of 60 years.

It achieves over 50 % reduction in incidence of shingles in all age groups, and over 60 % reduction in Post herpetic neuralgia.

The vaccine is not covered by the PBS, and will cost $280.00. DVA Gold card holders, however can access the Vaccine on prescription for $6, and Private Health insurance rebate is around $150, if patients are covered.

It is a live vaccine, so Immuno suppressed patients, with the following conditions will not be able to have the vaccine leukaemia, lymphoma and other bone marrow or blood diseases, and those […]

May 19th, 2014|Clinic News|

Shingles vaccine ,Zostavax

The risk of shingles in Australia has doubled between 2000 and 2010.Shingles will often cause a painful, debilitating illness with extensive skin lesions, and the possibility of long term nerve damage. About 30% of people with shingles develop Post herpetic neuralgia, defined as significant pain lasting more than 3 months after shingles.

The shingles vaccine has been recommended by Australian Immunisation authorities since 2009, but the vaccine has rarely been available, so we did not promote it until now, when it is readily available.

Zostavax is the adult varicella vaccine, and is 14 times more potent than the childhood varicella or chickenpox vaccine.

It is recommended for adults over the age of 60 years.

It achieves over 50 % reduction in incidence of shingles in all age groups, and over 60 % reduction in Post herpetic neuralgia.

The vaccine is not covered by the PBS, and will cost $280.00. DVA Gold card holders, however can access the Vaccine on prescription for $6, and Private Health insurance rebate is around $150, if patients are covered.

It is a live vaccine, so Immuno suppressed patients, with the following conditions will not be able to have the vaccine leukaemia, lymphoma and other bone marrow or blood diseases, and those […]

May 19th, 2014|Clinic News|